These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21745351)

  • 1. Female gender is a factor of worse outcome in acute stroke even after thrombolytic treatment.
    Martínez-Sánchez P; Fuentes B; Alonso de Leciñana M; Masjuan J; Simal P; Egido J; Díaz-Otero F; García-Pastor A; Gil-Nuñez A; Reig G; Vivancos J; Díez-Tejedor E;
    Int J Stroke; 2011 Aug; 6(4):371-2. PubMed ID: 21745351
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic therapy for acute ischemic stroke].
    Mori E
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():33-7. PubMed ID: 17469531
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 11. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Flaherty ML; Kissela B; Khatri P
    Neurology; 2007 Feb; 68(9):710-1; author reply 711. PubMed ID: 17328117
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Kurth T; Heuschmann PU; Walker AM; Berger K
    Neurology; 2007 Feb; 68(9):710; author reply 711. PubMed ID: 17325289
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and safety of intravenous thrombolysis for acute ischaemic stroke in northern Greece.
    Rudolf J; Tsivgoulis G; Deretzi G; Heliopoulos I; Vadikolias K; Tsiptsios I; Piperidou C
    Int J Stroke; 2011 Feb; 6(1):91-2. PubMed ID: 21205250
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Herzig R; Zapletalová J; Horák D; Král M; Skoloudík D; Bártková A; Veverka T; Heřman M; Kaňovský P
    Acta Neurol Scand; 2011 May; 123(5):339-44. PubMed ID: 20597864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 17. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
    Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
    Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant tissue plasminogen activator for both pulmonary and cerebral embolism.
    Yeguiayan JM; Benatru I; Guiu B; Taam JA; Albertini S; Freysz M; Giroud M
    Am J Emerg Med; 2011 Oct; 29(8):961.e1-4. PubMed ID: 21030188
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries.
    Martins SC; Friedrich MA; Brondani R; de Almeida AG; de Araújo MD; Chaves ML; Berger JR; Massaro AR
    J Stroke Cerebrovasc Dis; 2011; 20(5):459-64. PubMed ID: 20813552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.